TY - JOUR
T1 - P16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma : no association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary
AU - McDowell, Lachlan J.
AU - Young, Richard J.
AU - Johnston, Meredith L.
AU - Tan, Tze-Jian
AU - Kleid, Stephen
AU - Liu, Chen S.
AU - Bressel, Mathias
AU - Estall, Vanessa
AU - Rischin, Danny
AU - Solomon, Benjamin
AU - Corry, June
PY - 2016
Y1 - 2016
N2 - BACKGROUND The incidence of p16 overexpression and the role of human papillomavirus (HPV) in cutaneous head and neck squamous cell carcinoma (cHNSCC) are unclear. METHODS One hundred forty-three patients with cHNSCC lymph node metastases involving the parotid gland were evaluated for p16 expression by immunohistochemistry. The detection of 18 high-risk HPV subtypes was performed with HPV RNA in situ hybridization for a subset of 59 patients. The results were correlated with clinicopathological features and outcomes. RESULTS The median follow-up time was 5.3 years. No differences were observed in clinicopathological factors with respect to the p16 status. p16 was positive, weak, and negative in 45 (31%), 21 (15%), and 77 cases (54%), respectively. No high-risk HPV subtypes were identified, regardless of the p16 status. The p16 status was not prognostic for overall (hazard ratio, 1.08; 95% confidence interval [CI], 0.85-1.36; P =.528), cancer-specific (hazard ratio, 1.12; 95% CI, 0.77-1.64; P =.542), or progression-free survival (hazard ratio, 1.03; 95% CI, 0.83-1.29; P =.783). Distant metastasis-free survival, freedom from locoregional failure, and freedom from local failure were also not significantly associated with the p16 status. CONCLUSIONS p16 positivity is common but not prognostic in cHNSCC lymph node metastases. High-risk HPV subtypes are not associated with p16 positivity and do not appear to play a role in this disease. HPV testing, in addition to the p16 status in the unknown primary setting, may provide additional information for determining a putative primary site.
AB - BACKGROUND The incidence of p16 overexpression and the role of human papillomavirus (HPV) in cutaneous head and neck squamous cell carcinoma (cHNSCC) are unclear. METHODS One hundred forty-three patients with cHNSCC lymph node metastases involving the parotid gland were evaluated for p16 expression by immunohistochemistry. The detection of 18 high-risk HPV subtypes was performed with HPV RNA in situ hybridization for a subset of 59 patients. The results were correlated with clinicopathological features and outcomes. RESULTS The median follow-up time was 5.3 years. No differences were observed in clinicopathological factors with respect to the p16 status. p16 was positive, weak, and negative in 45 (31%), 21 (15%), and 77 cases (54%), respectively. No high-risk HPV subtypes were identified, regardless of the p16 status. The p16 status was not prognostic for overall (hazard ratio, 1.08; 95% confidence interval [CI], 0.85-1.36; P =.528), cancer-specific (hazard ratio, 1.12; 95% CI, 0.77-1.64; P =.542), or progression-free survival (hazard ratio, 1.03; 95% CI, 0.83-1.29; P =.783). Distant metastasis-free survival, freedom from locoregional failure, and freedom from local failure were also not significantly associated with the p16 status. CONCLUSIONS p16 positivity is common but not prognostic in cHNSCC lymph node metastases. High-risk HPV subtypes are not associated with p16 positivity and do not appear to play a role in this disease. HPV testing, in addition to the p16 status in the unknown primary setting, may provide additional information for determining a putative primary site.
UR - https://hdl.handle.net/1959.7/uws:63934
U2 - 10.1002/cncr.29901
DO - 10.1002/cncr.29901
M3 - Article
SN - 0008-543X
VL - 122
SP - 1201
EP - 1208
JO - Cancer
JF - Cancer
IS - 8
ER -